Moderna to Present at BMO 2019 Prescriptions for Success Healthcare Conference
A live webcast of the presentation will be available under “Events and Presentations” in the Investors section of the Moderna website at https://investors.modernatx.com/. A replay of the webcast will be archived on Moderna’s website for 30 days following the presentation.
About Moderna
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.
Headquartered in Cambridge, Mass., Moderna currently has strategic
alliances for development programs with
View source version on businesswire.com: https://www.businesswire.com/news/home/20190618005078/en/
Source:
Moderna Contact:
Investors:
Lavina Talukdar
Head
of Investor Relations
617-209-5834
lavina.talukdar@modernatx.com